Stifel Financial Corp Ab Cellera Biologics Inc. Transaction History

Stifel Financial Corp

$93.2 Billion
Q3 2024

A detailed history of Stifel Financial Corp transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 74,814 shares of ABCL stock, worth $202,745. This represents 0.0% of its overall portfolio holdings.

Number of Shares

74,814

Previous 102,377 26.92%

Holding current value

$202,745

Previous $303,000 36.3%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.39 - $3.49 $65,875 - $96,194	-27,563 Reduced 26.92%	74,814 $193,000
Q2 2024 Aug 13, 2024	SELL	$2.73 - $4.73 $18,837 - $32,637	-6,900 Reduced 6.31%	102,377 $303,000
Q1 2024 May 13, 2024	SELL	$4.29 - $5.97 $3,723 - $5,181	-868 Reduced 0.79%	109,277 $495,000
Q4 2023 Feb 12, 2024	BUY	$3.91 - $5.93 $177,991 - $269,945	45,522 Added 70.44%	110,145 $628,000
Q3 2023 Nov 13, 2023	SELL	$4.6 - $7.95 $14,673 - $25,360	-3,190 Reduced 4.7%	64,623 $297,000
Q2 2023 Aug 14, 2023	SELL	$5.66 - $7.59 $27,218 - $36,500	-4,809 Reduced 6.62%	67,813 $438,000
Q1 2023 May 12, 2023	SELL	$7.31 - $11.18 $14,334 - $21,923	-1,961 Reduced 2.63%	72,622 $547,000
Q4 2022 Feb 13, 2023	BUY	$9.48 - $14.52 $3,090 - $4,733	326 Added 0.44%	74,583 $755,000
Q3 2022 Nov 14, 2022	BUY	$9.2 - $13.68 $114,834 - $170,753	12,482 Added 20.21%	74,257 $734,000
Q2 2022 Aug 15, 2022	BUY	$5.72 - $10.65 $128,414 - $239,092	22,450 Added 57.09%	61,775 $658,000
Q1 2022 May 13, 2022	BUY	$7.46 - $14.14 $3,759 - $7,126	504 Added 1.3%	39,325 $383,000
Q4 2021 Feb 14, 2022	SELL	$12.99 - $17.73 $411,770 - $562,023	-31,699 Reduced 44.95%	38,821 $555,000
Q3 2021 Nov 15, 2021	BUY	$14.85 - $21.34 $720,447 - $1.04 Million	48,515 Added 220.47%	70,520 $1.41 Million
Q2 2021 Aug 13, 2021	BUY	$20.19 - $34.17 $297,519 - $503,529	14,736 Added 202.72%	22,005 $484,000
Q1 2021 May 14, 2021	BUY	$23.29 - $53.2 $169,295 - $386,710	7,269 New	7,269 $247,000

Others Institutions Holding ABCL

# of Institutions

154

Shares Held

109M

Call Options Held

153K

Put Options Held

194K

View Full List

About AbCellera Biologics Inc.

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $773M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

More about ABCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Ab Cellera Biologics Inc. Transaction History